Growth Metrics

TELA Bio (TELA) Cash from Operations (2018 - 2026)

TELA Bio has reported Cash from Operations over the past 8 years, most recently at 4870000.0 for Q4 2025.

  • For Q4 2025, Cash from Operations rose 35.33% year-over-year to 4870000.0; the TTM value through Dec 2025 reached 28219000.0, up 32.16%, while the annual FY2025 figure was 28219000.0, 32.16% up from the prior year.
  • Cash from Operations for Q4 2025 was 4870000.0 at TELA Bio, up from 5719000.0 in the prior quarter.
  • Over five years, Cash from Operations peaked at 4870000.0 in Q4 2025 and troughed at 14384000.0 in Q1 2024.
  • A 5-year average of 9092550.0 and a median of 9285500.0 in 2021 define the central range for Cash from Operations.
  • Biggest five-year swings in Cash from Operations: plummeted 107.6% in 2022 and later surged 36.34% in 2025.
  • Year by year, Cash from Operations stood at 9588000.0 in 2021, then decreased by 14.55% to 10983000.0 in 2022, then dropped by 0.62% to 11051000.0 in 2023, then soared by 31.85% to 7531000.0 in 2024, then skyrocketed by 35.33% to 4870000.0 in 2025.
  • Business Quant data shows Cash from Operations for TELA at 4870000.0 in Q4 2025, 5719000.0 in Q3 2025, and 7905000.0 in Q2 2025.